The company posted a second quarter net profit of NIS 4.8 million, compared with NIS 27,000 for the corresponding quarter.
Ilex Medical Ltd. (TASE:ILX) posted NIS 51 million revenue for the second quarter of 2006, 47% more than the NIS 35 million posted for the corresponding quarter of 2005. The company posted a net profit of NIS 4.8 million for the second quarter, compared with NIS 27,000 for the corresponding quarter.
Ilex Medical also announced a dividend policy under which it will distribute at least a third of its profits each year. The company will distribute a dividend of NIS 5 million in addition to a NIS 6 million dividend distributed earlier this year.
The company attributed its improved results mostly to sales of Chiron Corporation’s blood testing kits for AIDS and hepatitis by Ilex South Africa pty Ltd. Ilex is the exclusive franchisee of Chiron in South African and other southern and eastern African countries. Ilex also recorded its first revenue from a multi-year OEM contract with Olympus Corp. (TSE: 7733; DAX: OLY; Pink Sheets: OCPNY), under which Ilex provides its eLab laboratory software solutions.
Published by Globes [online], Israel business news - www.globes.co.il - on August 28, 2006
© Copyright of Globes Publisher Itonut (1983) Ltd. 2006